30 related articles for article (PubMed ID: 8604508)
1. Human immunodeficiency virus prevalence, incidence, and residual risk of transmission by transfusions at Retrovirus Epidemiology Donor Study-II blood centers in Brazil.
Sabino EC; Gonçalez TT; Carneiro-Proietti AB; Sarr M; Ferreira JE; Sampaio DA; Salles NA; Wright DJ; Custer B; Busch M;
Transfusion; 2012 Apr; 52(4):870-9. PubMed ID: 21981109
[TBL] [Abstract][Full Text] [Related]
2. HTLV infection in blood donors from Mato Grosso do Sul state: a closer look at HTLV screening in Brazilian blood banks.
Amianti C; Bandeira LM; Romeiro JS; Nakao BRO; Vavas MTM; Domingos JA; de Oliveira Uehara SN; Motta-Castro ARC
Sci Rep; 2023 Sep; 13(1):14524. PubMed ID: 37667056
[TBL] [Abstract][Full Text] [Related]
3. Detection of unreported usage of the antiretroviral drug lamivudine in two blood donors.
Nishiya A; Salles N; de Almeida-Neto C; Ferreira S; Nogueira F; Rocha V; Mendrone-Júnior A
Transfusion; 2023 Nov; 63(11):2106-2113. PubMed ID: 37702479
[TBL] [Abstract][Full Text] [Related]
4. Race as a Research Variable: Should It be Retained or Discarded?
Relf MV; Holt L; Kirton C; Overstreet K; Ramos SR; Swanson B; Webel A
J Assoc Nurses AIDS Care; 2021 Sep-Oct 01; 32(5):531-533. PubMed ID: 35137718
[No Abstract] [Full Text] [Related]
5. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.
Kleinman S; King MR; Busch MP; Murphy EL; Glynn SA; ;
Transfus Med Rev; 2012 Oct; 26(4):281-304, 304.e1-2. PubMed ID: 22633182
[TBL] [Abstract][Full Text] [Related]
6. [Controlled viral risks].
Barin F
Transfus Clin Biol; 2000 Feb; 7(1):24-9. PubMed ID: 10730343
[TBL] [Abstract][Full Text] [Related]
7. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
[TBL] [Abstract][Full Text] [Related]
9. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
Houareau C; Offergeld R
Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
[TBL] [Abstract][Full Text] [Related]
10. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies against hepatitis B virus core antigen among blood donors].
Moncharmont P; Bourgeot C; Papon S; Duraffourg M
Transfus Clin Biol; 2000 Feb; 7(1):63-9. PubMed ID: 10730347
[TBL] [Abstract][Full Text] [Related]
12. Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors.
Korelitz JJ; Busch MP; Kleinman SH; Williams AE; Zuck TF; Gilcher RO; Ownby HE; Co Chien H; Nemo GJ
Transfusion; 1996 Mar; 36(3):232-7. PubMed ID: 8604508
[TBL] [Abstract][Full Text] [Related]
13. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
